Management of epilepsy in pregnancy: What we still need to learn
Safe pregnancies have been a major concern for women with epilepsy. With more than 50 years of research, we have learned that antiseizure medications (ASMs) differ in their teratogenic risk. Valproate is associated with greater risks for malformations and adverse neurodevelopmental outcomes than oth...
Main Authors: | Torbjörn Tomson, Leihao Sha, Lei Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Epilepsy & Behavior Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589986423000424 |
Similar Items
-
Managing reproductive problems in women with epilepsy of childbearing age
by: Wanlin Lai, et al.
Published: (2021-11-01) -
Antiseizure medication in early nervous system development. Ion channels and synaptic proteins as principal targets
by: Patricio A. Castro, et al.
Published: (2022-10-01) -
The impact of epilepsy and antiseizure medications on pregnancy and neonatal outcomes: A nationwide cohort study
by: Cheng‐Yen Kuo, et al.
Published: (2023-12-01) -
Pregnancy‐related knowledge in women with epilepsy in childbearing age: A pilot questionnaire survey from China
by: Qiwei Li, et al.
Published: (2024-02-01) -
Competency in the management of women of childbearing age with epilepsy among primary care and specialist doctors in Estonia
by: Ringo L. Teesaar, et al.
Published: (2023-01-01)